Skip to main content
SpringerLink
Log in
Book cover

Diabetic Neuropathy pp 243–257Cite as

Clinical Features of Diabetic Polyneuropathy

  • Chapter

Part of the book series: Clinical Diabetes ((CLD))

Abstract

Neuropathy affects approximately 30–50% of all diabetic patients and is the commonest form of neuropathy in the developed world. It encompasses several neuropathic syndromes including focal and symmetrical neuropathies, by far the commonest of which is distal symmetrical neuropathy. The two main clinical consequences, foot ulceration sometimes leading to amputation and painful neuropathy, are associated with much patient morbidity and mortality. There is now little doubt that glycaemic control and duration of diabetes are major determinants of distal symmetrical neuropathy. In addition potentially modifiable, traditional markers of macrovascular disease such as hypertension, hyperlipidaemia and smoking are also independent risk factors.

There is now increasing evidence that the cause of distal symmetrical neuropathy may be nerve ischaemia, though metabolic factors may be important early. Pain is the most distressing symptom of neuropathy and the main factor that prompts the patient to seek medical advice. Pain may also occur within the context of all neuropathic syndromes associated with diabetes, including focal neuropathies. In acute painful neuropathies the pain indeed the neuropathy is self-limiting and usually subsides within a year.

Abnormalities of autonomic function are very common in subjects with longstanding diabetes; however, clinically significant autonomic dysfunction is uncommon. Several systems including the cardiovascular, gastrointestinal and genitor-urinary systems may be affected. Focal (asymmetrical) neuropathies including diabetic amyotrophy are well-recognised complications of diabetes. They have a relatively rapid onset and cause major disability, but there may be complete recovery.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Referenfces

  1. Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev 1999; 7:245–252.

    Google Scholar 

  2. Tesfaye S, Stephens L, Stephenson J, et al. The prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377–1384.

    Article  PubMed  CAS  Google Scholar 

  3. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150–154.

    Article  PubMed  CAS  Google Scholar 

  4. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456–1461.

    Article  PubMed  CAS  Google Scholar 

  5. Ziegler D. Diagnosis, staging and epidemiology of diabetic peripheral neuropathy. Diab Nutr Metab 1994;7:342–348.

    Google Scholar 

  6. Tesfaye S, Chaturvedi N, Eaton SEM, Witte D, Ward JD, Fuller J. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341–350.

    Article  PubMed  CAS  Google Scholar 

  7. Boulton AJM, Kirsner RS, Viliekyte L. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48–55.

    Article  PubMed  CAS  Google Scholar 

  8. Tesfaye S. Diabetic neuropathy: achieving best practice. Br J Vasc Dis 2003;3:112–117.

    Google Scholar 

  9. Watkins PJ, Edmonds ME. Clinical features of diabetic neuropathy, in Textbook of Diabetes (Pickup J, Williams G, eds.), 1997, Vol. 2, pp. 50.1–50.20.

    Google Scholar 

  10. Ward JD. Clinical features of diabetic neuropathy. in Diabetic Neuropathy (Ward JD, Goto Y, eds.), Chichester, UK., Wiley, 1990, pp. 281–296.

    Google Scholar 

  11. Bruyn GW, Garland H. Neuropathies of endocrine origin. in Handbook of clinical neurology (Vinken PJ, Bruyn GW, eds.), Amsterdam, North-Holland Publishing Co., 1970, Vol. 8, 29p.

    Google Scholar 

  12. Thomas PK. Metabolic neuropathy. J Roy Coll Phys (Lond) 1973;7:154–160.

    CAS  Google Scholar 

  13. Low PA, Suarez GA. Diabetic neuropathies. in Bailliere’s Clinical Neurology 1995;4(3):401–425.

    PubMed  CAS  Google Scholar 

  14. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic Somatic neuropathies. Diabetes Care 2004;27:1458–1486.

    Article  PubMed  Google Scholar 

  15. Eaton SEM, Tesfaye S. Clinical manifestations and measurement of somatic neuropathy. Diabetes Rev 1999;7:312–325.

    Google Scholar 

  16. Scott LA, Tesfaye S. Measurement of somatic neuropathy for clinical practice and clinical trials. Curr Diabetes Rep 2001;1:208–215.

    Article  CAS  Google Scholar 

  17. Andersen H, Jakobsen J. Motor function in diabetes. Diabetes Rev 1999;7:326–341.

    Google Scholar 

  18. Watkins PJ. Pain and diabetic neuropathy. Br Med J 1984;288:168–169.

    CAS  Google Scholar 

  19. Tesfaye S, Price D. Therapeutic approaches in diabetic neuropathy and neuropathic pain. in Diabetic Neuropathy. (Boulton AJM, ed.), 1997;159–181.

    Google Scholar 

  20. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996;348:1696–1701.

    Article  Google Scholar 

  21. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;(Suppl 1):S1–S8.

    Google Scholar 

  22. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 1981;21:18–24.

    Article  PubMed  CAS  Google Scholar 

  23. Ward JD. The diabetic leg. Diabetologia 1982;22:141–147.

    Article  PubMed  CAS  Google Scholar 

  24. Rajbhandari SM, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 1085–1096.

    Google Scholar 

  25. Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA. Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Roy Soc Med 1983;76:1011–1014.

    CAS  PubMed  Google Scholar 

  26. Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arterial venous shunting? Diabetologia 1982;22:6–8.

    Article  PubMed  CAS  Google Scholar 

  27. Edmonds ME, Archer AG, Watkins PJ. Ephedrine: a new treatment for diabetic neuropathic oedema. Lancet 1983;1(8324):548–551.

    Article  PubMed  CAS  Google Scholar 

  28. Said G, Slama G, Selva J. Progressive centripital degeneration of of axons in small-fibre type diabetic polyneuropathy. A clinical and pathological study. Brain 1983; 106:791.

    Article  PubMed  Google Scholar 

  29. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000;43:957–973.

    Article  PubMed  CAS  Google Scholar 

  30. Veves A, Young MJ, Manes C, et al. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a Clinical study. Diabetes Care 1994;17:1200–1202.

    Article  PubMed  CAS  Google Scholar 

  31. Ward JD, Tesfaye S. Pathogenesis of diabetic neuropathy. in Textbook of Diabetes (Pickup J, Williams G, eds.), 1997, Vol. 2, pp. 49.1–49.19.

    Google Scholar 

  32. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001;44:1973–1988.

    Article  PubMed  CAS  Google Scholar 

  33. Tesfaye S, Harris N, Jakubowski J, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993;36:1266–1274.

    Article  PubMed  CAS  Google Scholar 

  34. Eaton SE, Harris ND, Ibrahim S, et al. Differnces insural nerve haemodynamics in painful and painless neuropathy. Diabetologia 2003;934–939.

    Google Scholar 

  35. Malik RA, Tesfaye S, Newrick PG, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578–585.

    Article  PubMed  CAS  Google Scholar 

  36. Boulton AJM, Armstrong WD, Scarpello JHB, Ward JD. The natural history of painful diabetic neuropathy — a 4 year study. Postgrad Med J 1983;59:556–559.

    PubMed  CAS  Google Scholar 

  37. Benbow SJ, Chan AW, Bowsher D, McFarlane IA, Williams G. A prospective study of painful symptoms, small fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabetic Med 1994; 11:17–21.

    PubMed  CAS  Google Scholar 

  38. Chan AW, MacFarlane IA, Bowsher DR, Wells JC, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with non-diabetic population. Pain Clin 3 1990;147–159.

    Google Scholar 

  39. Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 1986;35:192–197.

    Article  PubMed  CAS  Google Scholar 

  40. Tsigos C, White A, Young RJ. Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function. Diabetic Med 1992;9:359–365.

    PubMed  CAS  Google Scholar 

  41. Veves A, Manes C, Murray HJ, Young MJ, Boulton AJM. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993;16:1187–1189.

    Article  PubMed  CAS  Google Scholar 

  42. Young MJ, Manes C, Boulton AJM. Vibration perception threshold predicts foot ulceration: a prospective study (Abstract). Diabetic Med 1992;9(Suppl 2):542.

    Google Scholar 

  43. Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia 2005;48:805–807.

    Article  PubMed  CAS  Google Scholar 

  44. Archer AG, Watkins PJ, Thomas PJ, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neorosurg Psychiatr 1983;46:491–496.

    CAS  Google Scholar 

  45. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974;23:418–423.

    PubMed  CAS  Google Scholar 

  46. Guy RJC, Clark CA, Malcolm PN, Watkins PJ. Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia, 1985;28:131.

    PubMed  CAS  Google Scholar 

  47. Caravati CM. Insulin neuritis: a case report. Va Med Mon 1933;59:745–746.

    Google Scholar 

  48. Tesfaye S, Malik R, Harris N, et al. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329–335.

    Article  PubMed  CAS  Google Scholar 

  49. Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (Berl) 1986;72: 157–163.

    Article  CAS  Google Scholar 

  50. Tesfaye S, Harris N, Wilson RM, Ward JD. Exercise induced conduction veolcity increment: a marker of impaired nerve blood flow in diabetic neuropathy. Diabetologia 1992;35:155–159.

    Article  PubMed  CAS  Google Scholar 

  51. Kihara M, Zollman PJ, Smithson IL, et al. Hypoxic effect of endogenous insulin on normal and diabetic peripheral nerve. Am J Physiol 1994;266:E980–E985.

    PubMed  CAS  Google Scholar 

  52. Matikainen E, Juntunen J. Diabetic neuropathy: Epidemiological, pathogenetic, and clinical aspects with special emphasis on type 2 diabetes mellitus. Acta Endocrinol Suppl (Copenh) 1984;262:89–94.

    Google Scholar 

  53. Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus: a clinicopathological study. Brain 1970;93:555–557.

    Article  PubMed  CAS  Google Scholar 

  54. Garland H. Diabetic amyotrophy. Br Med J 1955;2:1287–1290.

    PubMed  CAS  Google Scholar 

  55. Coppack SW, Watkins PJ. The natural history of femoral neuropathy. Q J Med 1991; 79:307–313.

    PubMed  CAS  Google Scholar 

  56. Casey EB, Harrison MJG. Diabetic amyotrophy: a follow-up study. Br Med J 1972;1:656.

    PubMed  CAS  Google Scholar 

  57. Garland H, Taverner D. Diabetic myelopathy. Br Med J 1953;1:1405.

    PubMed  CAS  Google Scholar 

  58. Subramony SH, Willbourn AJ. Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci 1982;53:293–304.

    Article  PubMed  CAS  Google Scholar 

  59. Bastron JA, Thomas JE. Diabetic polyradiculoneuropathy: clinical and electromyographic findings in 105 patients. Mayo Clinic Proc 1981;56:725–732.

    CAS  Google Scholar 

  60. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;33:559–569.

    Article  Google Scholar 

  61. Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003;27:465–470.

    Article  PubMed  Google Scholar 

  62. Steward JD, McKelvey R, Durcan L, Carpenter S, Karpati G. Chronic inflammatory demyelinating polyneuropathy (CIPD) in diabetes. J Neurol Sci 1996;142:59–64.

    Article  Google Scholar 

  63. Koller H, Kieseier BC, Jander S, Hartung H. Chronic Inflammatory Demyelinating Polyneuropathy. NEJM 2005;352:1343–1356.

    Article  PubMed  Google Scholar 

  64. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc sub-committee of the America Academy of Neurology AIDS Task Force. Neurology 1991;41:617–618.

    Google Scholar 

  65. Wilson JR, Park Y, Fisher MA. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy. Electromyogr Clin Neurophsiol 2000;40:181–185.

    CAS  Google Scholar 

  66. Molenaar DS, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64: 84–89.

    PubMed  CAS  Google Scholar 

  67. Gabriel CM, Howard R, Kinsella N, et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000;69:442–446.

    Article  PubMed  CAS  Google Scholar 

  68. Vital C, Vital A, Lagueny A, et al. Chronic inflammatory demyelinating polyneuropathy; immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases. Ultrastruct Pathol 2000;24:363–369.

    Article  PubMed  CAS  Google Scholar 

  69. Cocito D, Ciaramitaro P, Isoardo G, et al. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP. J Neurol 2002;249:719–722.

    Article  PubMed  Google Scholar 

  70. Sharma KR, Cross J, Ayyar DR, Martinez-Arizala A, Bradley WG. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol 2002; 59:751–757.

    Article  PubMed  Google Scholar 

  71. Zorilla E, Kozak GP. Ophthalmoplegia in diabetes mellitus. Ann Internal Med 1967;67:968–976.

    Google Scholar 

  72. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 1960;64:592–600.

    PubMed  CAS  Google Scholar 

  73. Leslie RDG, Ellis C. Clinical course following diabetic ocular palsy. Postgrad Med J 1978;54:791–792.

    Google Scholar 

  74. Dreyfuss PM, Hakim S, Adams RD. Diabetic ophthalmoplegia. Arch Neurol Psychiatry 1957;77:337–349.

    Google Scholar 

  75. Ellenberg M. Diabetic truncal mononeuropathy—a new clincal syndrome. Diabetes Care 1978;1:10–13.

    Article  PubMed  CAS  Google Scholar 

  76. Boulton AJM, Angus E, Ayyar DR, Weiss R. Diabetic thoracic polyradiculopathy presenting as abdominal swelling. BMJ 1984;289:798–799.

    PubMed  CAS  Google Scholar 

  77. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817–824.

    PubMed  CAS  Google Scholar 

  78. Clayburgh RH, Beckenbaugh RD, Dobyns JH. Carp[el tunnel release in patients with diffuse peripheral neuropathy. J Hand Surg 1987;12A:380–383.

    Google Scholar 

  79. White JES, Bullock RF, Hudgson P, Home PD, Gibson GJ. Phrenic neuropathy in association with diabetes. Diabet Med 1992;9:954–956.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Research Unit, Royal Hallamshire Hospital, Sheffield, UK

    Solomon Tesfaye MD, FRCP

Authors
  1. Solomon Tesfaye MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Aristidis Veves MD, DSc

  2. Manchester Royal Infirmary and University of Manchester, Manchester, UK

    Rayaz A. Malik MBChB, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Tesfaye, S. (2007). Clinical Features of Diabetic Polyneuropathy. In: Veves, A., Malik, R.A. (eds) Diabetic Neuropathy. Clinical Diabetes. Humana Press. https://doi.org/10.1007/978-1-59745-311-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-311-0_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-626-9

  • Online ISBN: 978-1-59745-311-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation